Are You Eligible for the Zantac Class Action Lawsuit?
If you’ve been diagnosed with cancer after taking ranitidine heartburn medicine, contact Cueto Law
Zantac heartburn medicine, or ranitidine, has provided relief to millions of Americans, making it one of the top-selling prescribed and over-the-counter drugs on the market for the past 30 years. But in April 2020, the U.S. Food and Drug Administration (FDA) required all manufacturers to immediately pull their ranitidine medications off the shelves due to their cancer risk.
For many patients with stomach, bladder or esophageal cancer, the move came too late, and they are now left to deal with the physical ramifications caused by a pharmaceutical giant who placed consumer safety second to their own profits.
A class action lawsuit filed against Zantac manufacturer Sanofi claims the company knew about the risk of the carcinogen N-Nitrosodimethylamine (NDMA) in its ranitidine heartburn medicine since the 1980s, but failed to change the formula or provide warnings to medical professionals and consumers. Because the risk increases over time and with continual use, patients who have taken Zantac for years now find themselves battling a disease more life-threatening than the condition the medication was supposed to treat.
If you live in Missouri or Illinois, and you or a family member has been diagnosed with cancer after taking Zantac heartburn medicine, contact the class action attorneys at Cueto Law in Belleville at 618-277-1554. We can help determine if you have a case against Sanofi and the steps you can take to be compensated for medical bills, lost wages, and other costs incurred from your cancer treatment.